🇺🇸 FDA
Pipeline program

10-week smoking cessation group therapy combined with NicoDerm CQ

NIDA-15774-2

Phase 3 other completed

Quick answer

10-week smoking cessation group therapy combined with NicoDerm CQ for Tobacco Use Cessation is a Phase 3 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tobacco Use Cessation
Phase
Phase 3
Modality
other
Status
completed

Clinical trials